CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma
Author
Andersen MN
Buijze M
+12Â more
de Bruijn J
Groen RWJ
Holthof LC
Li F
Lokhorst HM
Mutis T
Ruiter RWJ
van de Donk NWCJ
van der Horst HJ
van Hal-van Veen SE
Yuan H
Zweegman S
Publication venue
'Ferrata Storti Foundation (Haematologica)'
Publication date
31/01/2020
Field of study
Get PDF
Queen Mary Research Online